http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113355319-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a3d7e466c44c7b54e2a48e4bf62665ef |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2417 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-01 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-07 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N13-00 |
| filingDate | 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c64471b1c9c0c493bbb35a1acc652b6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a6376dc70e8e4a611b41f0f44dc3d44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc7898df5e8affb01d5783763e77da2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0fb67a070992bd7da7afb7f292925b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87f9aff9b5e2f1a889a8b04f95470af7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41710980a2399bc3fdbb7cbecdc5b372 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb7060fa43b4e2c520db6de7014a703f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d18ed564caab3a2584841c9720b86d |
| publicationDate | 2021-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113355319-A |
| titleOfInvention | Method for improving metabolic capability of bacillus amyloliquefaciens and producing alpha-amylase activity by adopting vacuum ultraviolet radio frequency plasma |
| abstract | The invention belongs to the field of strain activity improvement, and relates to a method for improving the metabolic capacity of bacillus amyloliquefaciens and producing alpha-amylase activity by adopting vacuum ultraviolet radio frequency plasma, which comprises the steps of placing an LB (Luria Bertani) flat plate full of the bacillus amyloliquefaciens in cold plasma treatment equipment, and enabling a strain to generate energy level transition after being radiated by vacuum ultraviolet photons in a cold plasma environment; the cold plasma processing equipment takes helium as a cold plasma gas source, and the helium generates helium high-energy plasma and vacuum ultraviolet photons through radio frequency discharge. The whole process of the invention has no heating, is in low-temperature pipeline production, does not generate mutagenesis to the strain molecules, does not generate influence on the active molecular structure, only aims at the energy level change of the molecules, has higher treatment effect, can directly carry out inoculation fermentation after the treatment is finished, abandons the fussy bacteria screening process, greatly shortens the production period, simplifies the production process, and can effectively save the labor, material resources and time cost of companies and enterprises. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113999799-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113999799-A |
| priorityDate | 2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.